SCHEMBL12475211

SCHEMBL12475211

Nc1c(C(=O)O)cccc1-c1nncc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.45
NR4A2 P43354 1/20 0.45
NR4A3 Q92570 1/20 0.45
EGFR P00533 2/20 0.41
KDR P35968 2/20 0.41
CDC25B P30305 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 1/20 0.41
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 1/20 0.40
MCL1 Q07820 1/20 0.38
ACMSD Q8TDX5 1/20 0.38
HAVCR2 Q8TDQ0 1/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL228596 0.87 NR4A1 (0.47) NR4A1NR4A2NR4A3EGFRKDR
SCHEMBL26134757 0.84 ALDH1A1 (0.46) NR4A1NR4A2NR4A3EGFRKDR
SCHEMBL12475214 0.81 NR4A1 (0.45) NR4A1NR4A2NR4A3EGFRKDR
SCHEMBL11794625 0.76 NR4A1 (0.61) NR4A1NR4A2NR4A3CDC25BMEN1
SCHEMBL6614659 0.75 ADORA2A (0.49) EGFRKDRKMT2AHSD17B10ALDH1A1
SCHEMBL2228819 0.74 SMN1; SMN2 (0.47) EGFRKDRALDH1A1KDM4EHPGD
SCHEMBL30632058 0.74 SMN1; SMN2 (0.47) EGFRKDRALDH1A1KDM4EHPGD
SCHEMBL2541660 0.74 LMNA (0.40) NR4A1NR4A2NR4A3EGFRKDR
SCHEMBL17744802 0.72 G6PD (0.61) NR4A1NR4A2NR4A3MEN1KMT2A
SCHEMBL9851131 0.72 G6PD (0.65) NR4A1NR4A2NR4A3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616443-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS Exelixis, Inc. (US) 2013-07-24 EP claimed
WO-2012037132-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS EXELIXIS, INC. (US) 2012-03-22 WO claimed